One of the MoAbs tested, MEM-59 recognizing CD43, was found to markedly suppress HPC proliferation.
CD43 (leukosialin, sialophorin, the major sialoglycoprotein of leukocytes) is a highly sialylated glycoprotein with a unique primary structure that is expressed in high density on almost all mature leukocytes, except for a population of B cell^.^.^ Expression of this molecule has been reported to be defective in lymphocytes of patients with the X chromosome-linked immunodeficiency disorder, Wiskott-Aldrich syndrome. Although CD43 has been shown to transduce an activating signal to peripheral T cells: monocytes:
and neutrophils: its function remains unknown. Here, CD43 was found to transduce a signal triggering apoptosis of HPC, suggesting that this molecule may be involved in the regulation of HPC proliferation at early stages of hematopoiesis.
MATERIALS AND METHODS

Antibodies. F(ab'
? fragments of the Tuk 3 MoAb (CD349) were prepared by pepsin digestion (intact MoAb was removed by affinity chromatography on a Protein A-Sepharose column). The MEM-59 (CD43), MEM-43 (CD59), MEM-12 (HLA-DR"), MEM-85 (CD44), MEM-83 (CDlla), and AFT-01 (human a-fetoprotein") MoAbs, purified by affinity chromatography on a Protein A-Sepharose column, were provided by Dr V. HofejSi (Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Praha, Czech Republic); the specificities of MEM-59, -43, -85, and -83 were confirmed during the Fourth International Workshop on Leukocyte Differentiation Antigens. The Leu-5b (CD2), Leu-l2 (CD19), Leu-M3 (CD14), Leu-M1 (CD15), and Leu-l la (CD16) MoAbs conjugated with fluorescein isothiocyanate (FITC) were purchased from Becton Dickinson (San Jose, CA); IOP49d (CD49d) and JC159-FITC (glycophorin) were purchased from AMAC Inc (Westbrook, ME).
Cytokines. Human recombinant cytokines were used. Stem cell factor (SCF) and erythropoietin were purchased from R & D Systems (Minneapolis, MN); interleukin-3 (IL-3), IL-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF) were provided by Sandoz Inc (Basel, Switzerland); and G-CSF was purchased from Amgen Inc (Thousand Oaks, CA).
Isolation of CD34"LIN-cells. Normal bone marrow samples were aspirated from volunteers after informed consent was obtained. Mononuclear cells were first isolated from these aspirates by density gradient sedimentation using Ficoll-Paque (Pharmacia LKB, Uppsala, Sweden). Next, CD34' cells were isolated from the mononuclear cell population using the Ceprate LC34-biotin kit (CellPro Inc, Bothell, WA). The purity of CD34' cells ranged from 75% to 90%. These cells were resuspended in phosphate-buffered saline (PBS; pH 7.3) containing 1% bovine serum albumin (BSA) and 0.2% human immune globulin (Gamimune N; Miles Inc, Elkhart, IN) and incubated for 15 MoAbs against CD2, CD19, CD14, CD15, CD16 , and glycophorin. Propidium iodide (1 pg/mL) was added to each sample to exclude dead cells. The stained cells were sorted on a FACStar (Becton Dickinson) and gated for low side light scatter, propidium iodide-, sulphorhodaminehi8h, FITC-cells. Cells stained with isotype-matched irrelevant mAbs were used as a negative control. A population of CD34h"8h (CD34h")LIN-cells was collected; the purity of this population after reanalysis was greater than 90%.
Isolation of lymphocytes. Peripheral mononuclear leukocytes were isolated from the blood of healthy donors by Ficoll-Paque density gradient centrifugation. The isolated cells were stained with anti-CD14 MoAb and propidium iodide to exclude dead cells and were sorted on the FACStar. CD14-cells were collected.
Analysis of sulface CD43 expression. CD34+ cells, isolated from bone marrow by means of the Ceprate LC34-biotin kit, were resuspended in PBS containing 1% BSA, 0.2% human immune globulin, and 0.1% sodium azide and incubated for 15 minutes. The cells were then stained with F(ab')2 fragments of anti-CD34 MoAb (IgG3) labeled with sulphorhodamine and anti-CD43 MoAb (IgGl), followed by goat antimouse IgGl labeled with phycoerythrin. Next, the cells were incubated with mouse IgGl to block the cell-bound goat antibody, stained with the anti-LIN-FITC MoAbs, and analyzed by multiparameter flow cytometry on the FACstar. CD43 expression was measured on the CD34' cell population. Cells stained with isotype-matched irrelevant MoAbs were used as a negative control. Propidium iodide (1 pg/mL) was added before analysis to exclude dead cells.
Hematopoietic cell suspension cultures. CD34hiLIN-cells were cultured in Iscove's modified Dulbecco's medium (IMDM) containing 10% fetal calf serum (Hyclone Laboratories, Logan, UT), penicillin (50 U/mL), streptomycin (50 pg/mL), 2 mmom L-glutamine, and 10 pmoVL a-thioglycerol. SCF was used at a concentration of 50 ng/ml, while L-3, IL-6, and G-CSF were used at a concentration of 10 ng/mL. If not otherwise stated, 96-well tissue culture plates (Coming, Coming, NY) were used to culture the cells in the presence of immobilized MoAbs.
Immobilization of MoAbs to tissue culture plates. Tissue culture plates were incubated for 1 hour at 37°C with purified MoAbs dissolved in PBS. A total of 50, 350, or 10 pL of the MoAb solution, respectively, was applied to each well of a 96-well, 24-well, or Terasaki plate. The plates were then washed four times with PBS. The concentration of the MoAb solutions was 50 pg/mL (if not stated otherwise).
Harvesting of cells cultured with immobilized MoAbs. The cells cultured in the presence of immobilized MoAbs were treated for 45 minutes at 37°C with 0-sialoglycoprotein endopeptidase (Accurate Chemical and Scientific Corp, Westbury, NY), which was reconstituted according to the manufacturer's instruction and diluted 1:lO in RPM1 1640 medium. This enzyme cleaves surface CD43," removing the MEM-59 epitope (see Results), and releases the cells bound to immobilized MEM-59. The enzyme-treated cells were then harvested by gentle pipetting. Enzyme treatment did not affect the viability of the cells as determined by flow cytometry analysis of propidium iodide-stained cells or by trypan blue exclusion.
Hematopoietic progenitor cell assay. Cells were resuspended in IMDM containing 30% fetal calf serum, 1% BSA, 0.1 mmoVL 2-mercaptoethanol, 2 mmoK L-glutamine, 2% methylcellulose, SCF (25 ng/mL), IL-3 (10 ng/mL), GM-CSF (10 ng/mL), and erythropoietin (2 U/mL), and then plated in plastic 35-mm tissue culture dishes. After 14 days of culture at 37°C. hematopoietic colonies were enumerated using an inverted light microscope and scored as colonyforming unit-granulocyte/macrophage (CFU-GM), burst-forming unit-erythrocyte (BFU-E), and colony-forming unit-granulocyte/ erythrocyte/macrophage/megakaryocyte (CFU-GEMM) using standard criteria for their identification. IN) . The cells were incubated for 60 minutes at 37"C, washed in PBS, and resuspended in 100 pL of PBS containing 40 mmoVL NaCl, 30 mmoVL sodium citrate, streptavidin-FITC (2.5 pg/mL), and 0.1% Triton X-100. Cells were incubated in this solution for 30 minutes at room temperature in the dark. After washing in PBS, cells were resuspended in PBS containing 1% formaldehyde and analyzed by flow cytometry on a FACScan (Becton Dickinson).
RESULTS
Expression of CD43 on CD34' cells.
Cell surface expression of CD43 on human bone marrow CD34' cells was analyzed by multiparameter flow cytometry (Fig 1A) . Although all CD34' cells express CD43, CD43 expression on these cells is not homogenous: CD34high cells express a higher density of CD43 than do CD34'OW cells (Fig 1A) .
Inhibition (Fig 2) . The inhibition of proliferation was proportional to the concentration of MEM-59; the maximum inhibition was reached when the concentration of the MEM-59 solution used for coating the plate was 50 pg/mL and higher (Fig 2) . Similar results were obtained using the MTT cell proliferation assay (not shown; the effect of MEM-59 used at the 50 pg/mL concentration on CD34h'LIN-cell proliferation analyzed by MTT assay is shown in Table 1 other surface molecules expressed on CD34hiLIN-cells, including CD59, HLA-DR. CD1 ldCD18, and CD49dCD29, significantly affected their proliferation (Table 1) . Induction of apoptosis of CD34hiLIN-cells by anti-CD43 MoAb. The suppression of the proliferation of CD34hiLIN-cells by anti-CD43 MoAb may result either from the initiation of programmed cell death or inhibition of cell division (eg, by prevention of entrance into the cell cycle). To test whether MEM-59 induces cell death, the short-term effect of immobilized MEM-59 on the viability of CD34hiLIN-cells was analyzed. In contrast with control cells, the viability of cells cultured with various concentrations of MEM-59 for 48 hours was markedly decreased in a dose-dependent manner, indicating that MEM-59 induces cell death (Fig 3A) . No such effect was observed in CD34hiLIN-cell cultures treated with MoAbs recognizing CD59, HLA-DR, CD1 IdCD1 8, or CD49dCD29 (not shown). Likewise, soluble MEM-59 did not induce death of these cells (Fig 3B) .
To examine whether apoptosis is the mechanism responsible for anti-CD43 MoAb-induced cell death, CD34h'LINcells were cultured for 48 hours with immobilized MEM-59 and analyzed for the presence of intracellular DNA fragmentation using terminal deoxynucleotidyl transferase assay. A significant portion of the anti-CD43 MoAb-treated cells (19% of the live gated population) was found to be in a progressive stage of apoptosis, whereas virtually no apoptotic cells were detected in the negative control MoAbtreated cell population (Fig 4B) . In addition, many of the MEM-59-treated cells exhibited features characteristic of apoptosis, including cellular shrinkage, nuclear segmentation, membrane blebbing, and formation of vesicles ( Fig  4A) .
Inhibition of proliferation of single CD34*'LIN-cells by anti-CD43 MoAb. To distinguish whether MEM-59 induces death of HPC directly or whether this process is initiated by MEM-59-activated accessory cells (eg, via a secreted factor), single CD34hiLIN-cells were deposited onto Terasaki plates coated with MEM-59 and cultured in the presence of SCF, L-3, and G-CSF. After 5 days of culture, the plates were scored for the presence of proliferating cells. The number of wells containing proliferating cells was significantly lower in the MEM-59-coated plates (6 t 2 of 72; Table 2 ) as compared with those treated with the negative control MoAb (28 2 6 of 72), indicating that MEM-59 directly affects single CD34hiLIN-cells.
Sensitivity of different classes of progenitor cells to the anti-CD43 MoAb-induced cell death. To examine whether there are differences in the sensitivity of progenitor cells committed to individual hematopoietic lineages to anti-CD43 MoAb-induced cell death, the effect of immobilized MEM-59 on clonogenic progenitor cells present in the CD34hiLIN-cell population was tested. CD34hiLIN-cells were cultured in the presence of MEM-59 for 3 days and then assayed for hematopoietic progenitor cells. The numbers of assayable CFU-GM, BFU-E, and CFU-GEMM were markedly diminished in the anti-CD43 MoAb-treated cell population as compared with the control-treated population (Table 3) . Interestingly, BFU-E-and CFU-GEMM-derived colony formation was inhibited to a significantly greater extent then the formation of CFU-GM-derived colonies. Table 5 ). The number of assayable progenitor cells (especially BFU-E and CFU-GEMM) in the MEM-59-treated cell population cultured in the absence of the cytokines was slightly lower in comparison with that treated with the negative control MoAb (Table 4) . However, the killing of clonogenic progenitor cells in the MEM-59-treated CD34hiLIN-cell population was significantly more dramatic in the presence of cytokines (Table 4) .
Effect of anti-CD43 MoAb on the survival of dlrerentiated cells. To examine the relationship between the differentiation of HPC and their sensitivity to MEM-59-induced cell death, CD34'"LIN-cells were cultured in the presence of SCF, IL-3, and IL-6. After 3, 7, 14, and 28 days of culture, aliquots of these cells were collected and treated with immobilized MEM-59 for 48 hours. The survival of the MEM-59-treated cells was measured by MTT assay. Only cells cultured in the presence of the cytokines for less than a week underwent apoptosis in response to the MEM-59-mediated stimulation. In contrast, cells cultured under these conditions for 7 or more days lost their sensitivity to MEM-59-induced cell death (Table 5) . Over a prolonged time of culture, these cells gradually lost surface CD34 expression and acquired CD15 and CD14 antigens-markers associated with myeloid differentiation (data not shown).
Effect of anti-CD43 MoAb on the survival of lymphocytes. To test whether MEM-59 directly induces apoptosis of peripheral lymphocytes, resting and phytohemagglutinin (PHA)-or L-7-activated peripheral mononuclear leukocytes depleted of monocytes were cultured in the presence of immobilized MEM-59 or the negative control MoAb.
(Monocytes were removed to eliminate any effect of these cells that may be stimulated by MEM-59.) After 2 or 5 days of culture, the viability of the MoAb-treated cells was analyzed. The viability of resting or IL-7-activated cells treated with the negative control MoAb remained high (approximately 80% to 90%) during the first 48 hours of culture (Fig 6 ) . After 5 days, the viability of the resting control cells dropped slightly, while the viability of L-7-activated cells remained virtually constant. In contrast, the viability of cells cultured for 48 hours with the negative control MoAb in the presence of PHA was relatively low (approximately 40%), but increased after 5 days. However, in all instances, MEM-59 did not have a significant effect on the viability of lymphocytes as compared with the negative control MoAb.
Characterization of the CD43 epitope recognized by MEM-59. To examine whether the CD43 epitope recognized by MEM-59 is dependent on sialic acid, KGla cells that express CD43 were treated with neuraminidase and stained with MEM-59. Binding of MEM-59 to neuraminidase-treated KGla cells was significantly reduced in comparison with mock-treated control cells (Fig 7A) . In addition, the reactivity of MEM-59 with KGla cells was virtually lost after treatment with 0-sialoglycoprotein endopeptidase ( Fig  7B) . not involve accessory cells. In addition, the initiation of this process is cytokine-dependent and requires crosslinking of surface CD43. It appears that dimerization of CD43 molecules on the cell surface is not sufficient and that at least three CD43 molecules must be crosslinked to induce apoptosis, as only immobilized, but not bivalent soluble, anti-CD43 MoAb is effective. This finding correlates well with the recently described requirement of receptor trimerization or aggregation for signaling via apoptosis-initiating molecules, which are members of the tumor necrosis factor receptor superfamily.'' The inhibition of cell proliferation and induction of cell death by anti-CD43 MoAb were analyzed by two independent methods. Cell proliferation was measured by cell count and MTT assay; cell death was measured by flow cytometry analysis of propidium iodide-stained cells and MTT assay (in addition, programmed cell death was detected by termjnal deoxynucleotidyl transferase assay). The results obtained by these alternative methods correlated well with each other. The MTT assay, in contrast to the above-mentioned alternative methods, is performed in situ and, therefore, does not require cells bound to immobilized anti-CD43 MoAb to be released and harvested from the plate by 0-sialoglycoprotein endopeptidase. Cells bound to immobilized MoAbs recognizing surface molecules that do not belong to the family of highly sialylated mucin-like glycoproteins and that are not cleaved by this enzyme cannot be easily harvested. Therefore, the proliferation of cells cultured in the presence of these immobilized MoAbs, including MoAbs recognizing Experiment CFU-GM BFU-E CFU-GEMM CFU-GM BFU-E CFU- GEMM   1  269  41  l 7  158  5  0  2  201  251  39  52  22  3  3  254  24  12  148  5 CD59, HLA-DR, CD1 1dCD18, and CD49d/CD29, was exclusively analyzed by MTT assay. The CD34h'LIN-cell population includes progenitor cells committed to individual hematopoietic lineages, as well as multipotential progenitor cells and stem cells. All three classes of progenitor cells present in the CD34hiLIN-cell population (CFU-GM, BFU-E and CFU-GEMM) were affected by MEM-59-induced cell death. However, the CFU-GM appeared to be less sensitive to the killing when compared with the BFU-E and CFU-GEMM. In contrast with primitive CD34h'LIN-cells, more differentiated cells with a myeloid phenotype derived from this population did not undergo apoptosis in response to MEM-59-induced stimula- 1  311  59  26  281  41  21  2  122  90  15  115  51  13  3  261  182  23  222  114  19  Cytokines  1  234  134  26  128  26  7  2  144  178  20  72  35  3  3  243  112  22  152 distinctly to the CD43-mediated stimulation. It is not known whether this is due to differences in the primary CD43 signal transduction mechanisms or whether the same signal-transduction pathway triggers different cellular responses. Currently, little is known about the mechanisms responsible for signal transduction via CD43 in myeloid cells. In T cells, the cytoplasmic domain of CD43 that is hyperphosphorylated during cell activation'"''' has been shown to be essential for the signal transduction.' It is, therefore, likely that CD43 is associated in the cell membrane with other molecules participating in CD43 signaling. The identification of these CD43 has been suggested to function as an alternate receptor for CD54 (intercellular adhesion molecule-l).'2 However, the CD54-binding capacity of CD43 has not been confirmed.",24 In addition, a human recombinant CD54-Fc fusion protein (provided by Drs K. Leiby and D. Gearing, SyStemix Inc, Palo Alto, CA) immobilized to the surface of tissue culture plates via an Fc-specific antihuman IgG goat antibody did not affect the proliferation of CD34hiLIN-cell population (not shown). Thus, which natural ligand interacts with CD43 remains unclear. A lectin may be one of the CD43 counterreceptor candidates, as MEM-59 binds to a sialic acid-dependent epitope. This epitope could be involved in the initiation of cellular responses to CD43-mediated stimulation, at least in HPC. The question of whether apoptosis induced via CD43 occurs in vivo also requires further study. The fact that the signal transduced via this molecule triggers apoptosis in certain cell types and initiates or enhances proliferation in others indicates that CD43 may regulate the proliferation of hematopoietic cells in a similar fashion to the T-cell receptor2s and some members of the tumor necrosis factor receptor superfamily, including receptors for tumor necrosis factor, FAS/APO-I, and CD3O.I' In vivo, CD43-mediated programmed cell death may function as a powerful negative regulatory mechanism to dampen excessive expansion of progenitor cells. The relatively short period of time during which primitive HPC are sensitive to CD43-mediated killing, before they further differentiate, is compatible with this hypothesis. Alternatively, CD43 may deliver a positive proliferative signal to these cells if combined with a second, so far unknown, stimulus. In this scenario, in the absence of
MEM-59
Control MEM-59 Effect of neuraminidase and 0-sialoglycoprotein endopeptidase on the reactivity of KGla cells with MEM-59. KGla cells were incubated in PBS with neuraminidase (A) or in RPM1 1640 medium with 0-sialoglycoprotein endopeptidase (B) (treated) or in medium alone for 45 minutes at 37°C. The activity of neuraminidase (Sigma, St Louis, MO) was 0.5 UlmL; the activity of 0-sialoglycoprotein endopeptidase was the same as that used to release the cells from immobilized MEM-59 (see Materials and Methods). Cells were then washed and stained with MEM-59, AFP-01 (isotype control), and MEM-85 (A) or MEM-83 (B), followed by goat antimouse lg labeled with FITC. The stained cells were analyzed by flow cytometry. On the x-axis log green fluorescence is shown; t h e y-axis shows cell number. The reactivities of MEM-83 (CDlla) and MEM-85 (CD441 with the target molecules are not effected by the particular enzymatic treatment; these MoAbs were used as controls.
< as integrins, which are involved in HPC interactions with bone marrow stroma, should be considered. Monocytes and neutrophils have been shown to respond to CD43-mediated stimulation by integrin-dependent homotypic aggregation:.* indicating a connection between integrins and membrane signaling via CD43. However, further experiments are needed to address specifically this question. Regardless of which of the scenarios mentioned above occurs in vivo, the data presented here indicate that CD43 may be directly involved in the regulation of early hematopoietic events, delivering a potent signal for the apoptosis of HPC.
